Correspondence 0001437749-23-018918 from Pyxis Oncology, Inc. (PYXS) (CIK 0001782223) (PYXS)
Pyxis Oncology, Inc. (PYXS) (CIK 0001782223)
Date: June 29, 2023 · CIK: 0001782223 · Accession: 0001437749-23-018918
AI Filing Summary & Sentiment
File numbers found in text: 333-272510
Letter
pyxs20230623_corresp.htm
June 29, 2023
Via EDGAR
U.S. Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549-3720
Attention: Dillon Hagius
Re:
Acceleration Request for Pyxis Oncology, Inc.
Registration Statement on Form S-4 (File No. 333-272510)
Ladies and Gentlemen:
Pursuant to Rule 461 under the Securities Act of 1933, as amended, Pyxis Oncology, Inc. (the “Company”), hereby requests that the effective date of the Company’s Registration Statement on Form S-4, Registration Number 333-272510 (the “Registration Statement”) be accelerated so that the Company’s Registration Statement will become effective at 3:00 P.M., Eastern Time or as soon thereafter as practicable, on June 30, 2023, or at such later time as the Company or its counsel may orally request via telephone call to the staff of the Division of Corporation Finance of the U.S. Securities and Exchange Commission.
We would appreciate it if, as soon as the Registration Statement is declared effective, you would so inform Istvan A. Hajdu of Sidley Austin LLP at (212) 839-5651.
[Signature Page Immediately Follows]
Very truly yours,
/s/ Pamela Connealy
Show Raw Text
CORRESP 1 filename1.htm pyxs20230623_corresp.htm June 29, 2023 Via EDGAR U.S. Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549-3720 Attention: Dillon Hagius Re: Acceleration Request for Pyxis Oncology, Inc. Registration Statement on Form S-4 (File No. 333-272510) Ladies and Gentlemen: Pursuant to Rule 461 under the Securities Act of 1933, as amended, Pyxis Oncology, Inc. (the “Company”), hereby requests that the effective date of the Company’s Registration Statement on Form S-4, Registration Number 333-272510 (the “Registration Statement”) be accelerated so that the Company’s Registration Statement will become effective at 3:00 P.M., Eastern Time or as soon thereafter as practicable, on June 30, 2023, or at such later time as the Company or its counsel may orally request via telephone call to the staff of the Division of Corporation Finance of the U.S. Securities and Exchange Commission. We would appreciate it if, as soon as the Registration Statement is declared effective, you would so inform Istvan A. Hajdu of Sidley Austin LLP at (212) 839-5651. [Signature Page Immediately Follows] Very truly yours, /s/ Pamela Connealy Pamela Connealy Chief Financial Officer cc: Lara Sullivan, Pyxis Oncology, Inc. Asher Rubin, Sidley Austin LLP Frank Rahmani, Sidley Austin LLP Istvan A. Hajdu, Sidley Austin LLP